クリングルファーマ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4884/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2023/01/20 | 日証協 | 694,700株 | +64.04% | 450,400株 | +692.96% | 800,245株 | +43.71% | 251,612株 | +90.04% |
2023/01/13 | 日証協 | 423,500株 | +4.18% | 56,800株 | +222.73% | 556,845株 | +2.24% | 132,400株 | +447.11% |
2023/01/06 | 日証協 | 406,500株 | -1.22% | 17,600株 | -26.67% | 544,645株 | -1.86% | 24,200株 | -65.92% |
2022/12/30 | 日証協 | 411,500株 | -3.68% | 24,000株 | -24.53% | 554,945株 | -1.32% | 71,015株 | +9.74% |
2022/12/23 | 日証協 | 427,200株 | -9.01% | 31,800株 | -65.51% | 562,343株 | +13.09% | 64,710株 | -59.44% |
2022/12/16 | 日証協 | 469,500株 | -4.69% | 92,200株 | -24.73% | 497,243株 | -28% | 159,525株 | -6.11% |
2022/12/09 | 日証協 | 492,600株 | -11.5% | 122,500株 | +63.77% | 690,638株 | -0.86% | 169,900株 | -30.31% |
2022/12/02 | 日証協 | 556,600株 | +4.9% | 74,800株 | +605.66% | 696,638株 | -4.35% | 243,800株 | -14.79% |
2022/11/18 | 日証協 | 565,800株 | -10.45% | 22,800株 | -45.32% | 763,938株 | -3.73% | 36,900株 | +48.19% |
2022/11/11 | 日証協 | 631,800株 | -3.62% | 41,700株 | -62.83% | 793,538株 | -1.75% | 24,900株 | -37.59% |
2022/11/04 | 日証協 | 655,500株 | -1.94% | 112,200株 | +220.57% | 807,640株 | +0.22% | 39,900株 | +53.46% |
2022/10/28 | 日証協 | 668,500株 | -2.35% | 35,000株 | -29.15% | 805,840株 | -2.04% | 26,000株 | -28.37% |
2022/10/21 | 日証協 | 684,600株 | -5.79% | 49,400株 | +82.96% | 822,640株 | -2.58% | 36,300株 | +44.62% |
2022/10/14 | 日証協 | 726,700株 | -2.14% | 27,000株 | -88.53% | 844,440株 | -1.53% | 25,100株 | -37.11% |
2022/10/07 | 日証協 | 742,600株 | +1.34% | 235,400株 | +28.49% | 857,540株 | +4.93% | 39,911株 | -45.25% |
2022/09/30 | 日証協 | 732,800株 | +4% | 183,200株 | +64.3% | 817,229株 | -0.77% | 72,900株 | +266.33% |
2022/09/22 | 日証協 | 704,600株 | +0.21% | 111,500株 | -76.93% | 823,530株 | +1.74% | 19,900株 | -71.89% |
2022/09/16 | 日証協 | 703,100株 | +7% | 483,400株 | -6.54% | 809,430株 | +0.76% | 70,800株 | +12.2% |
2022/09/09 | 日証協 | 657,100株 | +9.46% | 517,200株 | +51.14% | 803,330株 | +6.78% | 63,100株 | -83.82% |
※株式分割は考慮していませんのでご注意ください。
Page Top